Screener
Protagonist Therapeutics PTGX Total Operating Expenses
Total Operating Expenses at other companies
Other financials
Where this comes from
Reported directly by Protagonist Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The source filing: Protagonist Therapeutics’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:17 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-091123
| Line item | Three Months Ended / June 30, 2026 | Three Months Ended / June 30, 2025 | Six Months Ended / June 30, 2026 | Six Months Ended / June 30, 2025 |
|---|---|---|---|---|
| Operating expenses: | ||||
| Research and development | 42,061 | 37,036 | 88,800 | 72,929 |
| General and administrative | 12,648 | 10,551 | 25,925 | 22,289 |
| Total operating expenses | 54,709 | 47,587 | 114,725 | 95,218 |
| Income (loss) from operations | 158,766 | (42,041) | 155,118 | (61,351) |
| Interest income | 6,429 | 7,406 | 12,305 | 14,979 |
| Other (expense) income, net | (81) | 36 | (28) | 118 |
| Income (loss) before income tax expense | 165,114 | (34,599) | 167,395 | (46,254) |
Item 1. Condensed Consolidated Financial Statements (unaudited)
FAQ
- What is Protagonist Therapeutics's total operating expenses?
- Protagonist Therapeutics (PTGX) reported total operating expenses of $54.71M in Q2 2026.
- How has Protagonist Therapeutics's total operating expenses changed year-over-year?
- Protagonist Therapeutics's total operating expenses increased by 15.0% year-over-year, from $47.59M to $54.71M.
- What is the long-term trend for Protagonist Therapeutics's total operating expenses?
- Over 4 years (2021 to 2025), Protagonist Therapeutics's total operating expenses has grown at a 7.4% compound annual growth rate (CAGR), from $153.2M to $204.14M.
- What does total operating expenses mean?
- The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.
Ask your AI about Protagonist Therapeutics's total operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude